علاج خراج ما حول البلعوم في غياب تفاعل تأقي سابق للبنسلين

References

DOI: 10.3390/children9050618

• Evaluation and treatment of respiratory problems is the first step, to which all the experts agree.
• Considering the microbiological characteristics of DNIs, parenteral administration of broad-spectrum antibiotic therapy covering both aerobic and anaerobic pathogens is strongly recommended.
• Generally, a beta-lactamase inhibitor-enhanced penicillin (amoxicillin-clavulanate, ampicillin-sulbactam) or a beta-lactamase-resistant antibiotic (cefoxitin, imipenem, meropenem), eventually combined with an anti-anaerobic drug (clindamycin or metronidazole), is recommended.
• Patients with previous anaphylactic reactions to penicillin may be treated with clindamycin.